News
-
-
-
PRESS RELEASE
Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs
Tacalyx extends seed round to over €14 M led by Thuja Capital to advance development of cancer therapeutics targeting TACAs, aiming to create novel treatment options for patients with specificity across solid tumor indications